Novoste 40 mm Seed Train Addresses Clinical Concern Over "Edge" Effect
This article was originally published in The Gray Sheet
Executive Summary
Novoste plans to introduce into ongoing European and U.S. clinical trials this quarter a longer seed train for the Beta-Cath radiotherapy catheter system, which is intended to prevent possible restenosis at the edge of the treatment zone of a coronary vessel.